CETAPHIL- octocrylene, avobenzone lotion 
Galderma Laboratories, L.P.

----------

Cetaphil® Daily Facial Moisturizer

ACTIVE INGREDIENT

Avobenzone  3%
Octocrylene 10%

PURPOSE

Sunscreen

USE(S)

WARNINGS

For external use only
Do not use on damaged or broken skin.
Stop use and ask a doctor if rash occurs.
When using this product keep out of eyes.
Rinse with water to remove.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS

INACTIVE INGREDIENTS:

Water, Diisopropyl Adipate, Cyclopentasiloxane, Glycerin, Glyceryl Stearate, PEG-100 Stearate, Polymethyl Methacrylate, Phenoxyethanol, Benzyl Alcohol, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Tocopheryl Acetate, Carbomer, Disodium EDTA, Sodium Hydroxide

Other Information

• Protect this product from excessive heat and direct sun.
• May stain some fabrics.

Questions?

1-866-735-4137

PRINCIPAL DISPLAY PANEL - 4 FL OZ Carton

                    

P57752-0 new carton

NEW LOOK

Cetaphil®          

Daily Facial
Moisturizer
AM

15 BROAD SPECTRUM
     SPF 15 (UVA/UVB)
     SUNSCREEN

All Skin Types

Ultra lightweight lotion hydrates
and protects skin

Glycerin

Oil-Free

Recommended
Skin Cancer Foundation
Daily Use

4 FL OZ (118 mL)


Distributed by:
Galderma Laboratories, L.P.
Dallas, TX 75201 USA

All trademarks are the property of their respective owners.


Made in Canada

cetaphil.com
P57752-0

CETAPHIL 
octocrylene, avobenzone lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0299-3928
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE10 g  in 100 mL
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE3 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
DIISOPROPYL ADIPATE (UNII: P7E6YFV72X)  
Cyclomethicone 5 (UNII: 0THT5PCI0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
PEG-100 STEARATE (UNII: YD01N1999R)  
Poly(Methyl Methacrylate; 450000 Mw) (UNII: Z47NNT4J11)  
Phenoxyethanol (UNII: HIE492ZZ3T)  
Benzyl Alcohol (UNII: LKG8494WBH)  
Acrylates/C10-30 Alkyl Acrylate Crosspolymer (60000 Mpa.S) (UNII: 8Z5ZAL5H3V)  
.Alpha.-Tocopherol Acetate (UNII: 9E8X80D2L0)  
Carbomer Homopolymer, Unspecified Type (UNII: 0A5MM307FC)  
Edetate Disodium (UNII: 7FLD91C86K)  
Sodium Hydroxide (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0299-3928-041 in 1 CARTON04/01/2000
1118 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02004/01/2000
Labeler - Galderma Laboratories, L.P. (047350186)
Establishment
NameAddressID/FEIBusiness Operations
G Production Inc.251676961manufacture(0299-3928)

Revised: 4/2024
Document Id: 8731dd5b-3ac1-42f8-b510-68f3e5104038
Set id: 2a6bc3f2-4e52-252b-d051-94be1ee0cc00
Version: 10
Effective Time: 20240416
 
Galderma Laboratories, L.P.